BR9711908A - Derivado do cido piperidinacetocarbox¡lico uso do mesmo e prepara-Æo farmac-utica para uso por via oral parenteral ou intraperitoneal - Google Patents

Derivado do cido piperidinacetocarbox¡lico uso do mesmo e prepara-Æo farmac-utica para uso por via oral parenteral ou intraperitoneal

Info

Publication number
BR9711908A
BR9711908A BR9711908A BR9711908A BR9711908A BR 9711908 A BR9711908 A BR 9711908A BR 9711908 A BR9711908 A BR 9711908A BR 9711908 A BR9711908 A BR 9711908A BR 9711908 A BR9711908 A BR 9711908A
Authority
BR
Brazil
Prior art keywords
piperidinacetocarboxylic
intraperitoneally
derived
pharmaceutical preparation
parenterally
Prior art date
Application number
BR9711908A
Other languages
English (en)
Inventor
Wilfried Lubisch
Achim Moeller
Juergen DELZER
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of BR9711908A publication Critical patent/BR9711908A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychology (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
BR9711908A 1996-10-15 1997-09-23 Derivado do cido piperidinacetocarbox¡lico uso do mesmo e prepara-Æo farmac-utica para uso por via oral parenteral ou intraperitoneal BR9711908A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19642591A DE19642591A1 (de) 1996-10-15 1996-10-15 Neue Piperidin-Ketocarbonsäure-Derivate, deren Herstellung und Anwendung
PCT/EP1997/005202 WO1998016512A1 (de) 1996-10-15 1997-09-23 Neue piperidin-ketocarbonsäure-derivate, deren herstellung und anwendung

Publications (1)

Publication Number Publication Date
BR9711908A true BR9711908A (pt) 1999-08-24

Family

ID=7808858

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9711908A BR9711908A (pt) 1996-10-15 1997-09-23 Derivado do cido piperidinacetocarbox¡lico uso do mesmo e prepara-Æo farmac-utica para uso por via oral parenteral ou intraperitoneal

Country Status (24)

Country Link
US (1) US6380220B1 (pt)
EP (1) EP0934273A1 (pt)
JP (1) JP2001501955A (pt)
KR (1) KR20000049130A (pt)
CN (1) CN1239950A (pt)
AR (1) AR009379A1 (pt)
AU (1) AU736754B2 (pt)
BG (1) BG103338A (pt)
BR (1) BR9711908A (pt)
CA (1) CA2268917A1 (pt)
CO (1) CO4930264A1 (pt)
CZ (1) CZ126899A3 (pt)
DE (1) DE19642591A1 (pt)
HR (1) HRP970549A2 (pt)
HU (1) HUP9904104A3 (pt)
IL (1) IL129089A0 (pt)
NO (1) NO991761L (pt)
NZ (1) NZ334979A (pt)
PL (1) PL332720A1 (pt)
RU (1) RU2189974C2 (pt)
SK (1) SK38599A3 (pt)
TR (1) TR199900819T2 (pt)
WO (1) WO1998016512A1 (pt)
ZA (1) ZA979175B (pt)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999054310A2 (de) 1998-04-20 1999-10-28 Basf Aktiengesellschaft Neue substituierte amide, deren herstellung und anwendung
WO1999054320A1 (de) * 1998-04-20 1999-10-28 Basf Aktiengesellschaft Neue heterocyclisch substituierte amide mit cystein-protease hemmender wirkung
WO1999054305A1 (de) 1998-04-20 1999-10-28 Basf Aktiengesellschaft Heterocyclisch substituierte amide als calpainhemmer
DE19817459A1 (de) * 1998-04-20 1999-10-21 Basf Ag Neue heterozyklische substituierte Amide, Herstellung und Anwendung
US6117870A (en) * 1998-11-12 2000-09-12 Fujirebio Kabushiki Kaisha Cyclic amide derivatives
AU6936500A (en) * 1999-08-24 2001-03-19 Regents Of The University Of California, The Non-quinoline inhibitors of malaria parasites
CZ20011872A3 (cs) 1999-09-29 2002-03-13 Ortho-Mcneil Pharmaceutical, Inc. Isonipekotamidy pro léčbu onemocnění zprostředkovaných integriny
AU2001267886A1 (en) 2000-06-30 2002-01-14 Seikagaku Corporation Epoxycarboxylic acid amides, azides and amino alcohols and processes for preparation of alpha-keto amides by using them
DE10114762A1 (de) * 2001-03-26 2002-10-02 Knoll Gmbh Verwendung von Cysteinprotease-Inhibitoren
EP1389205B1 (en) 2001-04-09 2005-12-21 Ortho-McNeil Pharmaceutical Research Inc. Quinazoline and quinazoline-like compounds for the treatment of integrin-mediated disorders
EP1539744A4 (en) 2002-07-11 2007-06-06 Vicuron Pharm Inc N-HYDROXYAMIDE DERIVATIVES WITH ANTIBACTERIAL EFFECT
WO2005019177A1 (en) * 2003-08-14 2005-03-03 Icos Corporation Aminopiperidine amide derivatives as vla-1 integrin antagonists and uses thereof
EP1682524A1 (en) * 2003-10-24 2006-07-26 Aventis Pharmaceuticals, Inc. Novel keto-oxadiazole derivatives as cathepsin inhibitors
AR064693A1 (es) 2006-12-29 2009-04-22 Abbott Gmbh & Co Kg Compuestos carboxamidas y su utilizacion en la elaboracion de un medicamento para el tratamiento de enfermedades asociadas a alta actividad de calpaina.
TWI453019B (zh) * 2007-12-28 2014-09-21 Abbvie Deutschland 甲醯胺化合物
TWI519530B (zh) 2009-02-20 2016-02-01 艾伯維德國有限及兩合公司 羰醯胺化合物及其作為鈣蛋白酶(calpain)抑制劑之用途
US8236798B2 (en) 2009-05-07 2012-08-07 Abbott Gmbh & Co. Kg Carboxamide compounds and their use as calpain inhibitors
US9051304B2 (en) 2009-12-22 2015-06-09 AbbVie Deutschland GmbH & Co. KG Carboxamide compounds and their use as calpain inhibitors V
US8598211B2 (en) 2009-12-22 2013-12-03 Abbvie Inc. Carboxamide compounds and their use as calpain inhibitors IV
JP2013544866A (ja) 2010-12-09 2013-12-19 アッヴィ・ドイチュラント・ゲー・エム・ベー・ハー・ウント・コー・カー・ゲー カルボキサミド化合物及びカルパイン阻害剤vとしてのその使用
SG11201406345XA (en) 2012-04-03 2014-11-27 Abbvie Deutschland Carboxamide compounds and their use as calpain inhibitors v
EP3426674A4 (en) 2016-03-09 2019-08-14 Blade Therapeutics, Inc. CYCLIC KETO AMID COMPOUNDS AS CALPAIN MODULATORS AND METHOD FOR THE PRODUCTION AND USE THEREOF
AU2017292646A1 (en) 2016-07-05 2019-02-07 Blade Therapeutics, Inc. Calpain modulators and therapeutic uses thereof
WO2018064119A1 (en) 2016-09-28 2018-04-05 Blade Therapeutics, Inc. Calpain modulators and therapeutic uses thereof
KR20200010220A (ko) 2017-06-01 2020-01-30 에자이 알앤드디 매니지먼트 가부시키가이샤 피라졸로퀴놀린 유도체를 함유하는 루이소체 질병 치료제
KR20200010211A (ko) 2017-06-01 2020-01-30 에자이 알앤드디 매니지먼트 가부시키가이샤 Pde9 저해제를 포함하는 약제학적 조성물
RU2020130022A (ru) * 2018-03-28 2022-05-04 Блэйд Терапьютикс, Инк. Модуляторы кальпаина и их терапевтическое применение

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8904298D0 (sv) * 1989-12-21 1989-12-21 Astra Ab New compounds
CA2098609A1 (en) * 1990-12-28 1992-06-29 Raymond T. Bartus Use of calpain inhibitors in the inhibition and treatment of neurodegeneration
WO1992012140A1 (en) 1990-12-28 1992-07-23 Georgia Tech Research Corporation Peptides ketoamides, ketoacids, and ketoesters
CA2071621C (en) 1991-06-19 1996-08-06 Ahihiko Hosoda Aldehyde derivatives
EP0650368A1 (en) * 1992-06-24 1995-05-03 Cortex Pharmaceuticals, Inc. Use of calpain inhibitors in the inhibition and treatment of medical conditions associated with increased calpain activity
US5541290A (en) * 1993-06-24 1996-07-30 Harbeson; Scott L. Optically pure calpain inhibitor compounds

Also Published As

Publication number Publication date
JP2001501955A (ja) 2001-02-13
CO4930264A1 (es) 2000-06-27
CA2268917A1 (en) 1998-04-23
AU4777097A (en) 1998-05-11
HUP9904104A3 (en) 2001-01-29
BG103338A (bg) 2000-01-31
AU736754B2 (en) 2001-08-02
US6380220B1 (en) 2002-04-30
SK38599A3 (en) 2000-04-10
CN1239950A (zh) 1999-12-29
IL129089A0 (en) 2000-02-17
RU2189974C2 (ru) 2002-09-27
PL332720A1 (en) 1999-10-11
KR20000049130A (ko) 2000-07-25
NO991761D0 (no) 1999-04-14
EP0934273A1 (de) 1999-08-11
HUP9904104A2 (hu) 2000-05-28
DE19642591A1 (de) 1998-04-16
ZA979175B (en) 1999-04-14
NO991761L (no) 1999-04-14
NZ334979A (en) 2001-02-23
TR199900819T2 (xx) 1999-06-21
HRP970549A2 (en) 1998-08-31
AR009379A1 (es) 2000-04-12
CZ126899A3 (cs) 1999-07-14
WO1998016512A1 (de) 1998-04-23

Similar Documents

Publication Publication Date Title
BR9711908A (pt) Derivado do cido piperidinacetocarbox¡lico uso do mesmo e prepara-Æo farmac-utica para uso por via oral parenteral ou intraperitoneal
GB2336663B (en) Gas-turbine engine combustion system
HUP0103388A3 (en) Oral liquid mucoadhesive compositions
GB9809829D0 (en) Gas-turbine engine combustor
DE69928378D1 (de) Geruchsverstärkende zusammensetzung für kosmetische produkte
AU5232299A (en) Pumpable/injectable phosphate-bonded ceramics
NO20001775L (no) Munnhygienepreparat til behandling av halitose
DE59701223D1 (de) Keramische klinge
NO20012979L (no) Fiberblanding for enterale sammensetninger
AU4413299A (en) Stabilized pharmaceutical compositions
DE69501892D1 (de) Keilverzahnung für gasturbinenwellenverbindung
BR9507771A (pt) Processos para preparação de ácido 1-Butil-2-(2'-(2H-Tetratozol-5-IL)-Bifenil-4-Ilmetil(-1H-Indol-3-Carboxílico
GB2326877B (en) Compositions for ceramic tiles
ITMI990676V0 (it) Impianto d'accensione per un motore endotermico
IT1296514B1 (it) Utilizzo di materiali ceramici contenenti componenti come cordierite e/o mullite e come carburi e/o nitruri per la fabbricazione di
DE69730398D1 (de) Sulfonamide und Verfahren zu ihrer Herstellung, Metall-chelates hergestellt aus den Sulfonamiden, und optisches Aufzeichnungsmaterial hergestellt aus den Metall-chelaten
DK0876199T3 (da) Blandehovedejektor
BR9701203A (pt) Processo para a preparaçÃo de um composto de 4,6-bis-(ariloxi)-pirimidina assimétrico e composto
EP0973533A4 (en) METHOD FOR INHIBITING BACTERIAL CYTOTOXICITY
ITMI981796A0 (it) Procedimento per la preparazione di r-(-)-carnitina
BR9610918A (pt) Composições para limpeza de superfície rígida
BR9711018A (pt) Processo para prepara-Æo de 6-amino-capro-nitrilina ou mistura de 6-amino-capro-nitrilina/hexa-metileno-diamina
ID21840A (id) Turunan-turunan oksopiperazinil dan komposisi-komposisi yang distabilkan terhadap cahaya
ID21347A (id) Alat untuk melepas atau mencampur bahan kental
HRP980081B1 (en) Internal-combustion rotary-piston engines

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]